SG149870A1 - Treatment with an oncolytic virus and an immunostimulant for in vivo enhancement of immune system recognition of neoplasms - Google Patents
Treatment with an oncolytic virus and an immunostimulant for in vivo enhancement of immune system recognition of neoplasmsInfo
- Publication number
- SG149870A1 SG149870A1 SG200900431-8A SG2009004318A SG149870A1 SG 149870 A1 SG149870 A1 SG 149870A1 SG 2009004318 A SG2009004318 A SG 2009004318A SG 149870 A1 SG149870 A1 SG 149870A1
- Authority
- SG
- Singapore
- Prior art keywords
- immunostimulant
- neoplasms
- treatment
- oncolytic virus
- immune system
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/765—Reovirus; Rotavirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71328705P | 2005-08-31 | 2005-08-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG149870A1 true SG149870A1 (en) | 2009-02-27 |
Family
ID=37808428
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG200900431-8A SG149870A1 (en) | 2005-08-31 | 2006-08-22 | Treatment with an oncolytic virus and an immunostimulant for in vivo enhancement of immune system recognition of neoplasms |
Country Status (13)
Country | Link |
---|---|
US (1) | US20070071723A1 (zh) |
EP (1) | EP1922085A4 (zh) |
JP (1) | JP2009504687A (zh) |
CN (1) | CN101304761A (zh) |
AR (1) | AR056487A1 (zh) |
AU (1) | AU2006287052B2 (zh) |
CA (2) | CA2825762A1 (zh) |
IL (1) | IL188816A0 (zh) |
MX (1) | MX2008002743A (zh) |
SG (1) | SG149870A1 (zh) |
TW (1) | TW200812614A (zh) |
WO (1) | WO2007025365A1 (zh) |
ZA (1) | ZA200800246B (zh) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6136307A (en) | 1997-08-13 | 2000-10-24 | Oncolytics Biotech Inc. | Reovirus for the treatment of cellular proliferative disorders |
US6110461A (en) * | 1997-08-13 | 2000-08-29 | Oncolytics Biotech Inc. | Reovirus for the treatment of neoplasia |
GB0720624D0 (en) * | 2007-10-20 | 2007-11-28 | Academisch Ziekenhuis Leiden | Viral Modification |
WO2009135614A2 (en) * | 2008-05-09 | 2009-11-12 | Bayer Schering Pharma Aktiengesellschaft | Use of a virus regimen for the treatment of diseases |
EP2408473B1 (en) | 2009-03-16 | 2016-03-16 | McMaster University | Vaccination methods |
US20100297072A1 (en) * | 2009-05-19 | 2010-11-25 | Depinho Ronald A | Combinations of Immunostimulatory Agents, Oncolytic Virus, and Additional Anticancer Therapy |
US9352006B2 (en) | 2010-10-20 | 2016-05-31 | Icahn School Of Medicine At Mount Sinai | Methods and compositions for treating tumors using myeloid derived suppressor cells |
CN108125989A (zh) * | 2011-04-12 | 2018-06-08 | 英特维特国际股份有限公司 | 溶瘤作用中的禽偏肺病毒 |
CN104427992B (zh) | 2012-01-25 | 2017-12-19 | 德那翠丝有限公司 | 生物标志物及使用溶瘤病毒和免疫调节剂的组合疗法 |
AU2013204555A1 (en) * | 2012-04-30 | 2013-11-14 | Oncolytics Biotech Inc. | Protecting modified viruses from neutralizing antibodies using the reovirus sigma 1 protein |
CN105658790A (zh) | 2013-02-21 | 2016-06-08 | 东安大略研究所儿童医院有限公司 | 疫苗组合物 |
JP6857498B2 (ja) * | 2014-02-27 | 2021-04-14 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | 癌を処置するための併用方法 |
MX2017009272A (es) * | 2015-01-16 | 2018-04-11 | Anticuerpos que penetran en células. | |
GB201504251D0 (en) | 2015-03-13 | 2015-04-29 | Virttu Biolog Ltd And University Of Sheffield The | Oncolytic herpes simplex virus infected cells |
US20170224796A1 (en) | 2016-02-05 | 2017-08-10 | Xeme Biopharma Inc. | Therapeutic Cancer Vaccine Containing Tumor-Associated Neoantigens and Immunostimulants in a Delivery System |
CN108338994A (zh) * | 2017-01-25 | 2018-07-31 | 杭州康万达医药科技有限公司 | 溶瘤病毒作为用于***和/或癌症的免疫刺激剂的应用 |
CA3138657A1 (en) * | 2019-05-09 | 2020-11-12 | Sator Therapeutics LLC | Delivery of oncolytic viruses using dendritic cells |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070275873A1 (en) * | 2004-04-29 | 2007-11-29 | Heidner Hans W | Methods and Compositions Comprising Protein L Immunoglobulin Binding Domains for Cell-Specific Targeting |
-
2006
- 2006-08-22 MX MX2008002743A patent/MX2008002743A/es active IP Right Grant
- 2006-08-22 AU AU2006287052A patent/AU2006287052B2/en not_active Ceased
- 2006-08-22 CA CA2825762A patent/CA2825762A1/en not_active Abandoned
- 2006-08-22 CN CNA200680031389XA patent/CN101304761A/zh active Pending
- 2006-08-22 SG SG200900431-8A patent/SG149870A1/en unknown
- 2006-08-22 CA CA2621127A patent/CA2621127C/en active Active
- 2006-08-22 WO PCT/CA2006/001377 patent/WO2007025365A1/en active Application Filing
- 2006-08-22 EP EP06790560A patent/EP1922085A4/en not_active Withdrawn
- 2006-08-22 ZA ZA200800246A patent/ZA200800246B/xx unknown
- 2006-08-22 JP JP2008526344A patent/JP2009504687A/ja active Pending
- 2006-08-25 TW TW095131267A patent/TW200812614A/zh unknown
- 2006-08-30 US US11/468,676 patent/US20070071723A1/en not_active Abandoned
- 2006-08-31 AR ARP060103826A patent/AR056487A1/es unknown
-
2008
- 2008-01-16 IL IL188816A patent/IL188816A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101304761A (zh) | 2008-11-12 |
AU2006287052B2 (en) | 2009-03-12 |
WO2007025365A1 (en) | 2007-03-08 |
CA2825762A1 (en) | 2007-03-08 |
JP2009504687A (ja) | 2009-02-05 |
IL188816A0 (en) | 2008-08-07 |
EP1922085A4 (en) | 2009-12-30 |
TW200812614A (en) | 2008-03-16 |
EP1922085A1 (en) | 2008-05-21 |
AR056487A1 (es) | 2007-10-10 |
CA2621127A1 (en) | 2007-03-08 |
CA2621127C (en) | 2014-02-25 |
AU2006287052A1 (en) | 2007-03-08 |
ZA200800246B (en) | 2009-08-26 |
US20070071723A1 (en) | 2007-03-29 |
MX2008002743A (es) | 2008-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG149870A1 (en) | Treatment with an oncolytic virus and an immunostimulant for in vivo enhancement of immune system recognition of neoplasms | |
MX2023000411A (es) | Vacuna combinada de sars-cov-2 e influenza. | |
WO2006074346A3 (en) | RNAi MODULATION OF RSV AND THERAPEUTIC USES THEREOF | |
TW200626720A (en) | Semi-soft C-Class immunostimulatory oligonucleotides | |
WO2007084775A3 (en) | Compositions and methods for modulation of suppressor t cell activation | |
FR2919804B1 (fr) | Composition et vaccin therapeutique anti-tumoral | |
WO2007002470A3 (en) | Inactivated chimeric vaccines and related methods of use | |
WO2009072767A3 (en) | A powerful vaccine composition comprising a lipopeptide and poly i:c as an adjuvant | |
WO2007120673A3 (en) | Immunogenic wt-1 peptides and methods of use thereof | |
MY160201A (en) | Immunostimulatory oligonucleotides | |
EA201170493A1 (ru) | Микроорганизмы и вакцины, зависимые от репликации неприродных аминокислот | |
BR0316758A (pt) | Vacinas baseadas em levedura como imunoterapia | |
WO2008085562A3 (en) | Combinatorieal therapy of cancer and infectious diseases with anti-b7-h1 antibodies | |
WO2011035205A3 (en) | Antibodies against candida, collections thereof and methods of use | |
BR112013011194A2 (pt) | partículas de glicoproteína semelhantes a vírus (vlps) da raiva. | |
WO2006062596A3 (en) | RNAi MODULATION OF RSV, PIV AND OTHER RESPIRATORY VIRUSES AND USES THEREOF | |
BRPI0816134A2 (pt) | Herpesvírus, sequência de dna, vetor, célula, vírus, método para produção de partículas infecciosas, partículas infecciosas, vacina, uso de herpesvírus ou da sequência de dna ou do vetor ou das partículas infecciosas, e, método para o tratamento preventivo e/ou terapêutico de uma doença. | |
MX2011008649A (es) | Vacuna contra el virus del dengue inactivado con un adyuvante libre de aluminio. | |
WO2006076003A3 (en) | Vaccinia virus strains | |
WO2011079073A3 (en) | Herpes simplex virus vaccines | |
MX2010006984A (es) | Vacunas contra la malaria. | |
GB2429711A (en) | Heart and skeletal muscle inflammation (HSMI) virus | |
MX2007002659A (es) | Composicion vacunal contra el virus de la hepatitis c. | |
WO2009137871A8 (en) | Methods of detecting cells with a disrupted cell membrane, cells infected with a pathogen, dying cells or dead cells | |
EA200301151A1 (ru) | Вакцина против натуральной оспы |